LabGenomics Co., Ltd. (KOSDAQ:084650)

LabGenomics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18,382	24,510	42,324	98,511	70,528	37,834
Short-Term Investments	61,653	66,354	73,066	38,461	28,470	15,351
Cash & Short-Term Investments	80,035	90,864	115,391	136,971	98,998	53,185
Cash Growth	-25.82%	-21.25%	-15.76%	38.36%	86.14%	273.97%
Accounts Receivable	44,747	37,765	37,123	35,317	68,417	31,550
Other Receivables	1,215	1,437	94.01	214.65	76.3	102.91
Receivables	46,259	39,518	37,230	35,531	68,493	31,652
Inventory	3,998	3,741	2,269	1,743	2,693	2,464
Prepaid Expenses	1,367	962.08	747.77	109.27	77.14	119.77
Other Current Assets	874.85	482.33	4,741	127.6	668.62	104.23
Total Current Assets	132,533	135,567	160,378	174,483	170,931	87,526
Property, Plant & Equipment	54,282	57,359	54,957	54,885	19,698	7,987
Long-Term Investments	15,411	15,656	20,253	16,354	10,700	7,392
Goodwill	58,188	58,327	54,890	0	0	-
Other Intangible Assets	23,219	24,369	21,124	871.46	266.27	231.83
Long-Term Accounts Receivable	-	-	-	-0	0	0
Long-Term Deferred Tax Assets	3,481	2,650	-	1,994	1,101	2,335
Long-Term Deferred Charges	-	-	43.74	143.71	473.28	1,421
Other Long-Term Assets	1,346	1,342	1,761	1,922	1,118	2,472
Total Assets	288,792	295,662	313,457	250,653	204,287	109,364
Accounts Payable	10,176	9,646	9,286	6,564	11,387	8,089
Accrued Expenses	3,119	3,613	6,327	2,148	501.44	462.51
Short-Term Debt	-	-	-	-	-	2,500
Current Portion of Long-Term Debt	32,590	44,711	29,252	-	-	100
Current Portion of Leases	2,162	2,621	1,957	1,033	919.83	1,196
Current Income Taxes Payable	2.16	2.17	91.45	5,434	21,646	9,757
Current Unearned Revenue	45.14	50.32	10.47	-	-	-
Other Current Liabilities	15,609	15,671	18,132	4,716	6,230	2,912
Total Current Liabilities	63,703	76,315	65,055	19,896	40,683	25,016
Long-Term Debt	13,000	-	16,000	19,200	3,200	-
Long-Term Leases	1,200	2,869	2,786	995.45	1,201	1,696
Long-Term Deferred Tax Liabilities	-	-	1,474	-	-	-
Other Long-Term Liabilities	14.18	163.36	-0	0	-0	0
Total Liabilities	77,917	79,348	85,314	40,142	45,865	27,723
Common Stock	37,180	37,180	37,180	17,056	5,725	5,725
Additional Paid-In Capital	19,384	19,384	19,314	16,687	29,097	29,110
Retained Earnings	141,241	146,617	170,243	174,863	129,740	46,880
Treasury Stock	-	-	-	-	-7,933	-1,390
Comprehensive Income & Other	13,070	13,134	1,058	725.12	1,087	1,219
Total Common Equity	210,875	216,314	227,795	209,331	157,715	81,543
Minority Interest	-	-	347.27	1,179	706.08	97.09
Shareholders' Equity	210,875	216,314	228,143	210,510	158,421	81,640
Total Liabilities & Equity	288,792	295,662	313,457	250,653	204,287	109,364
Total Debt	48,951	50,202	49,994	21,228	5,321	5,492
Net Cash (Debt)	31,084	40,662	65,396	115,743	93,678	47,694
Net Cash Growth	-45.77%	-37.82%	-43.50%	23.55%	96.42%	1590.23%
Net Cash Per Share	418.70	547.71	880.88	1709.14	1386.06	724.11
Filing Date Shares Outstanding	74.24	74.24	74.24	67.98	66.65	67.93
Total Common Shares Outstanding	74.24	74.24	74.24	67.98	66.65	67.93
Working Capital	68,830	59,252	95,323	154,587	130,248	62,510
Book Value Per Share	2840.45	2913.71	3068.37	3079.15	2366.39	1200.35
Tangible Book Value	129,467	133,618	151,781	208,459	157,449	81,311
Tangible Book Value Per Share	1743.90	1799.81	2044.47	3066.34	2362.40	1196.94
Land	21,016	21,016	21,016	21,286	3,061	1,275
Buildings	24,003	24,003	24,003	26,420	6,600	2,437
Machinery	5,027	5,029	4,527	3,918	2,685	2,438
Construction In Progress	-	-	16.5	414.2	5,307	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.